United States Biosimilar Drug Market Report 2016

Publisher Name :
Date: 06-Oct-2016
No. of pages: 120
Inquire Before Buying

Notes:

Sales, means the sales volume of Biosimilar Drug

Revenue, means the sales value of Biosimilar Drug

This report studies sales (consumption) of Biosimilar Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Hospira

- Sandoz

- Teva Pharmaceutical Industries

- Pfizer

- Merck Sharp & Dohme

- Celltrion

- Amgen

- Biogen

- Mylan

- Biocon

- Dr. Reddy's Laboratories

- Boehringer Ingelheim GmbH

- Intas Pharmaceuticals

- LG Life Sciences

- Emcure Pharmaceuticals

- Probiomed

- Biosidus

- 3SBio

- WOCKHARDT

- Sun Pharmaceutical Industries

- Shanghai Fosun Pharmaceutical

- Qilu Pharmaceutical

- Allergan

- Dongbao

- Samsung Biologics

- Zydus Cadila.

- Dong-A Pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Biosimilar Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Biosimilar Drug Market Report 2016

Table of Contents
United States Biosimilar Drug Market Report 2016
1 Biosimilar Drug Overview
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Classification of Biosimilar Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Biosimilar Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biosimilar Drug (2011-2021)
1.4.1 United States Biosimilar Drug Sales and Growth Rate (2011-2021)
1.4.2 United States Biosimilar Drug Revenue and Growth Rate (2011-2021)
2 United States Biosimilar Drug Competition by Manufacturers
2.1 United States Biosimilar Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biosimilar Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biosimilar Drug Average Price by Manufactures (2015 and 2016)
2.4 Biosimilar Drug Market Competitive Situation and Trends
2.4.1 Biosimilar Drug Market Concentration Rate
2.4.2 Biosimilar Drug Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Biosimilar Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Biosimilar Drug Sales and Market Share by Type (2011-2016)
3.2 United States Biosimilar Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Biosimilar Drug Price by Type (2011-2016)
3.4 United States Biosimilar Drug Sales Growth Rate by Type (2011-2016)
4 United States Biosimilar Drug Sales (Volume) by Application (2011-2016)
4.1 United States Biosimilar Drug Sales and Market Share by Application (2011-2016)
4.2 United States Biosimilar Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Biosimilar Drug Manufacturers Profiles/Analysis
5.1 Hospira
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Biosimilar Drug Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Hospira Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Sandoz
5.2.2 Biosimilar Drug Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Sandoz Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Teva Pharmaceutical Industries
5.3.2 Biosimilar Drug Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Teva Pharmaceutical Industries Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Pfizer
5.4.2 Biosimilar Drug Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Pfizer Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Merck Sharp & Dohme
5.5.2 Biosimilar Drug Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Merck Sharp & Dohme Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Celltrion
5.6.2 Biosimilar Drug Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Celltrion Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Amgen
5.7.2 Biosimilar Drug Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Biogen
5.8.2 Biosimilar Drug Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Biogen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Mylan
5.9.2 Biosimilar Drug Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Mylan Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Biocon
5.10.2 Biosimilar Drug Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Biocon Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Dr. Reddy's Laboratories
5.12 Boehringer Ingelheim GmbH
5.13 Intas Pharmaceuticals
5.14 LG Life Sciences
5.15 Emcure Pharmaceuticals
5.16 Probiomed
5.17 Biosidus
5.18 3SBio
5.19 WOCKHARDT
5.20 Sun Pharmaceutical Industries
5.21 Shanghai Fosun Pharmaceutical
5.22 Qilu Pharmaceutical
5.23 Allergan
5.24 Dongbao
5.25 Samsung Biologics
5.26 Zydus Cadila.
5.27 Dong-A Pharmaceutical
6 Biosimilar Drug Manufacturing Cost Analysis
6.1 Biosimilar Drug Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biosimilar Drug
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Biosimilar Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Biosimilar Drug Market Forecast (2016-2021)
10.1 United States Biosimilar Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Biosimilar Drug Sales Forecast by Type (2016-2021)
10.3 United States Biosimilar Drug Sales Forecast by Application (2016-2021)
10.4 Biosimilar Drug Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure United States Sales Market Share of Biosimilar Drug by Type in 2015
Table Application of Biosimilar Drug
Figure United States Sales Market Share of Biosimilar Drug by Application in 2015
Figure United States Biosimilar Drug Sales and Growth Rate (2011-2021)
Figure United States Biosimilar Drug Revenue and Growth Rate (2011-2021)
Table United States Biosimilar Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Biosimilar Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilar Drug Sales Share by Manufacturers
Figure 2016 Biosimilar Drug Sales Share by Manufacturers
Table United States Biosimilar Drug Revenue by Manufacturers (2015 and 2016)
Table United States Biosimilar Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Biosimilar Drug Revenue Share by Manufacturers
Table 2016 United States Biosimilar Drug Revenue Share by Manufacturers
Table United States Market Biosimilar Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Biosimilar Drug Average Price of Key Manufacturers in 2015
Figure Biosimilar Drug Market Share of Top 3 Manufacturers
Figure Biosimilar Drug Market Share of Top 5 Manufacturers
Table United States Biosimilar Drug Sales by Type (2011-2016)
Table United States Biosimilar Drug Sales Share by Type (2011-2016)
Figure United States Biosimilar Drug Sales Market Share by Type in 2015
Table United States Biosimilar Drug Revenue and Market Share by Type (2011-2016)
Table United States Biosimilar Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biosimilar Drug by Type (2011-2016)
Table United States Biosimilar Drug Price by Type (2011-2016)
Figure United States Biosimilar Drug Sales Growth Rate by Type (2011-2016)
Table United States Biosimilar Drug Sales by Application (2011-2016)
Table United States Biosimilar Drug Sales Market Share by Application (2011-2016)
Figure United States Biosimilar Drug Sales Market Share by Application in 2015
Table United States Biosimilar Drug Sales Growth Rate by Application (2011-2016)
Figure United States Biosimilar Drug Sales Growth Rate by Application (2011-2016)
Table Hospira Basic Information List
Table Hospira Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira Biosimilar Drug Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Biosimilar Drug Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Biosimilar Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Biosimilar Drug Sales Market Share (2011-2016)
Table Merck Sharp & Dohme Basic Information List
Table Merck Sharp & Dohme Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Sharp & Dohme Biosimilar Drug Sales Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celltrion Biosimilar Drug Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biosimilar Drug Sales Market Share (2011-2016)
Table Biogen Basic Information List
Table Biogen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogen Biosimilar Drug Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Biosimilar Drug Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Biosimilar Drug Sales Market Share (2011-2016)
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy's Laboratories Biosimilar Drug Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH Biosimilar Drug Sales Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Pharmaceuticals Biosimilar Drug Sales Market Share (2011-2016)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table LG Life Sciences Biosimilar Drug Sales Market Share (2011-2016)
Table Emcure Pharmaceuticals Basic Information List
Table Emcure Pharmaceuticals Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Emcure Pharmaceuticals Biosimilar Drug Sales Market Share (2011-2016)
Table Probiomed Basic Information List
Table Probiomed Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Probiomed Biosimilar Drug Sales Market Share (2011-2016)
Table Biosidus Basic Information List
Table Biosidus Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biosidus Biosimilar Drug Sales Market Share (2011-2016)
Table 3SBio Basic Information List
Table 3SBio Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table 3SBio Biosimilar Drug Sales Market Share (2011-2016)
Table WOCKHARDT Basic Information List
Table WOCKHARDT Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table WOCKHARDT Biosimilar Drug Sales Market Share (2011-2016)
Table Sun Pharmaceutical Industries Basic Information List
Table Sun Pharmaceutical Industries Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Industries Biosimilar Drug Sales Market Share (2011-2016)
Table Shanghai Fosun Pharmaceutical Basic Information List
Table Shanghai Fosun Pharmaceutical Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai Fosun Pharmaceutical Biosimilar Drug Sales Market Share (2011-2016)
Table Qilu Pharmaceutical Basic Information List
Table Qilu Pharmaceutical Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qilu Pharmaceutical Biosimilar Drug Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Biosimilar Drug Sales Market Share (2011-2016)
Table Dongbao Basic Information List
Table Dongbao Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dongbao Biosimilar Drug Sales Market Share (2011-2016)
Table Samsung Biologics Basic Information List
Table Samsung Biologics Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Samsung Biologics Biosimilar Drug Sales Market Share (2011-2016)
Table Zydus Cadila. Basic Information List
Table Zydus Cadila. Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Cadila. Biosimilar Drug Sales Market Share (2011-2016)
Table Dong-A Pharmaceutical Basic Information List
Table Dong-A Pharmaceutical Biosimilar Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dong-A Pharmaceutical Biosimilar Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure United States Biosimilar Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Biosimilar Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Biosimilar Drug Production Forecast by Type (2016-2021)
Table United States Biosimilar Drug Consumption Forecast by Application (2016-2021)
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 72
    C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2017, outlays comprehensive info......
  • C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 59
    C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - CXCR2 or Interleukin 8 receptor, beta is a chemokine receptor. It binds to IL8 with high affinity, and transduces the signal through a G-prot......
  • C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 54
    C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017 Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The latest report C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017, outlays comprehensive information on the C5a Anaphylato......
  • Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 53
    Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017 Summary Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Prostaglandin D2 (PGD2) receptors are G protein-coupled receptors that binds and is activated by prostaglandin D2. ......
  • Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 45
    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017 Summary According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. ......
  • Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 74
    Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017 Summary Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) pipeline Target constitutes close to 17 molecules. Out of which approximately 17 molecules are developed by Companies. The lat......
  • Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 49
    Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017 Summary Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut. GLP2 stimulates intestinal growth and up regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. GLP2 prevent......
  • Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 55
    Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017 Summary According to the recently published report 'Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017'; Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) pipeline Target constitutes close to 14 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. M......
  • Restenosis - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 48
    Restenosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H2 2017, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family hist......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs